Results 101 to 110 of about 699,523 (337)

Chandrasekhar equations for infinite dimensional systems [PDF]

open access: yes
Chandrasekhar equations are derived for linear time invariant systems defined on Hilbert spaces using a functional analytic technique. An important consequence of this is that the solution to the evolutional Riccati equation is strongly differentiable in
Ito, K., Powers, R. K.
core   +1 more source

Sensitivity analysis in a market with memory [PDF]

open access: yes, 2017
A general market model with memory is considered in terms of stochastic functional differential equations. We aim at representation formulae for the sensitivity analysis of the dependence of option prices on the memory.
Banos, David R.   +2 more
core  

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Oscillation of a perturbed nonlinear third order functional differential equation

open access: yesElectronic Journal of Qualitative Theory of Differential Equations, 2018
In this paper, the authors present some new results on the oscillatory and asymptotic behavior of solutions of the perturbed nonlinear third order functional differential equation $$ \left( b(t)\left( a(t)(x^{\prime }(t))^{\alpha }\right) ^{\prime ...
Said Grace, John Graef
doaj   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Analytic Solutions of an Iterative Functional Differential Equation near Resonance

open access: yesInternational Journal of Differential Equations, 2009
We investigate the existence of analytic solutions of a class of second-order differential equations involving iterates of the unknown function 𝑥(𝑧)+𝑐𝑥(𝑧)=𝑥(𝑎𝑧+𝑏𝑥(𝑧)) in the complex field ℂ. By reducing the equation with the Schröder transformation to
Tongbo Liu, Hong Li
doaj   +1 more source

On Nonautonomous Functional Differential Equations

open access: yesJournal of Mathematical Analysis and Applications, 1999
The author investigates the existence of an evolution family for the nonautonomous Cauchy problem \[ x'(t)= A(t) x(t),\quad 0\leq s\leq t\leq T,\quad x(s)= x, \] in a Banach space \(X\). Each \(A(t)\) is a linear operator on \(X\). The following result is obtained: Let \(X\), \(Y\), and \(D\) be Banach spaces, \(D\) densely and continuously imbedded in
openaire   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy